Zevra Therapeutics stock gapped down Wednesday after its first-ever quarterly profit missed even more bullish expectations.

Shares of Madison Square Garden Entertainment declined after the company swung to a wider loss than Wall Street expected in its latest quarter. The stock fell 11%, to $35.63, putting it on pace for ...

Key Points Non-GAAP EPS of $0.23 in Q2 2025 exceeded analyst expectations by $0.05, Adjusted earnings per share rose 76.9% year over year. GAAP revenue rose 26.9% to $123.1 million in Q2 2025, ...

As we move through the final peak week of earnings season, the blended growth rate for S&P 500 has now moved into the double digits, hitting 11.8% with 90% companies reporting. Thus far 81% of ...

Key Points GAAP sales rose 28% year over year to $12.1 million in Q2 2025 but missed the GAAP analyst estimate of $12.4 million. Adjusted EBITDA loss improved to $6.5 million, but profitability ...

V2X, a provider of supply and logistics services to the U.S. military, is emerging as a strong name in the operations side of the defense sector, according to BofA Securities. Formed in 2014, V2X ...

Chili's owner Brinker International reported fourth-fiscal-quarter results early Wednesday, fueling a premarket share-price pickup. Brinker International Inc. shares were surging early Wednesday after ...

After a mixed earnings report, there are more catalysts ahead for investors. Shares of CoreWeave have been volatile, and there could be more bumpiness down the road with the stock's lockup period set ...

Shares of Clearwater Analytics climbed 3% on Tuesday after Goldman Sachs upgraded the stock to buy from neutral, citing the ...

The next batch of inflation data from the Bureau of Labor Statistics was already shaping up to be a high-profile affair due ...

The number of S&P 500 companies mentioning 'recession' in earnings calls has dropped significantly from nearly 125 to under 25.

Earnings season slows this week, with investors waiting on NVIDIA’s earnings on August 27. Retail sales and inflation ...